David E. Wheadon - 16 Jul 2026 Form 4 Insider Report for Vaxart, Inc. (VXRT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Jul 2026, 21:50:05 UTC
Prior SEC filing
27 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Edward Berg, Attorney-in-Fact

Key filing fact

David E. Wheadon filed Form 4 for Vaxart, Inc. (VXRT) on 17 Jul 2026.

Key facts

  • This page summarizes David E. Wheadon's Form 4 filing for Vaxart, Inc. (VXRT).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 17 Jul 2026, 21:50.

Change

  • Previous filing in this sequence was filed on 27 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001789507 Primary reporting owner

Wheadon David E.

Relationship
Director
Address
C/O VAXART, INC., 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO
Signature
/s/ Edward Berg, Attorney-in-Fact
Signature date
17 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VXRT transaction

Common Stock

Award

Transaction value
Shares
+39,400
Change %
+84%
Price
$0.000000*
Shares after
86,150
Date
16 Jul 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VXRT transaction Derivative

Stock Options (right to buy)

Award

Transaction value
Shares
+78,700
Change %
Price
$0.000000*
Shares after
78,700
Date
16 Jul 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
78,700
Exercise price
$0.5149
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary date of the grant.

Footnote F2

The shares subject to this option shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary of the date of the grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .